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Summary
This study examines the effect of melatonin on leptin- induced changes in transition of 
histone to protamine in adult rats during spermatogenesis. Twelve- week- old Sprague- 
Dawley rats were randomised into control, leptin- , leptin–melatonin- 10- , leptin–
melatonin- 20- and melatonin- 10- treated groups with six rats per group. Leptin was 
given via intraperitoneal injections (i.p.) daily for 42 days (60 μg/kg body weight). Rats 
in the leptin- and melatonin- treated groups were given either 10 or 20 mg day−1 kg−1 
body weight of leptin in drinking water. Melatonin- 10- treated group received only 
10 mg of melatonin day−1 kg−1 body weight in drinking water for 42 days. Control rats 
received 0.1 ml of 0.9% saline. Upon completion of the treatment, sperm count, mor-
phology and histone- to- protamine ratio were estimated. Gene expression of HAT, 
HDAC1, HDAC2, H2B, H2A, H1, PRM1, PRM2, TNP1 and TNP2 was determined. 
Data were analysed using ANOVA. Sperm count was significantly lower, whereas the 
fraction of spermatozoa with abnormal morphology, the ratio of histone- to- protamine 
transition and the expressions of HAT, HDAC1, HDAC2, H2B, H2A, H1, PRM1 were 
significantly higher in leptin- treated rats than those in controls or melatonin- treated 
rats. It appears that exogenous leptin administration adversely affects histone- to- 
protamine transition, which is prevented by concurrent administration of melatonin.
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1  | INTRODUCTION
Leptin, a 16- kDa protein, is produced and secreted mainly by the adi-
pose tissue. It is a pleiotropic hormone that has been shown to have 
roles in diverse physiological processes including regulation of body 
weight and food intake, immune function, haematopoiesis, inflamma-
tion, sexual maturation and normal reproduction (Fantuzzi & Faggioni, 
2000; Mantzoros, 2000; Sayed- Ahmed, Abd- Elmaksoud, Elnasharty, & 
El- Magd, 2012; Waelput, Brouckaert, Broekaert, & Tavernier, 2006). 
However, a number of recent reports have indicated some adverse 
effects of leptin on sperm count and morphology. Exogenous admin-
istration of leptin to normal rats for 6 weeks was found to signifi-
cantly decrease sperm concentration while increasing the fraction of 
morphologically abnormal sperm and increase sperm DNA fragmen-
tation (Abbasihormozi et al., 2013; Almabhouh et al., 2014; Haron, 
D’Souza, Jaafar, Zakaria, & Singh, 2010; Haron, Singh, D’Souza, 
Jaafar, & Zakaria, 2013). Although the precise mechanism for this is 
still unknown, it is also unclear whether leptin affects the transition 
of histone to protamine. Protamines are the most abundant nucleo-
proteins in mature spermatozoa. During spermatogenesis, histones 
are first replaced by testis- specific histone variants, which are then 
replaced by transition proteins. The transition proteins in the condens-
ing chromatin are then replaced with protamines (Carrell, Emery, & 
Hammoud, 2007). Approximately 85%–95% of histones in the DNA 
are replaced by protamines, which help provide a tight packaging of 
the sperm DNA. This compaction of the nucleus and cessation of gene 
2 of 7  |     ALMABHOUH And SInGH
expression help protect the paternal DNA from damage and mutagen-
esis (Barratt et al., 2010; Conwell, Vilfan, & Hud, 2003; Oliva, 2006; 
Rathke, Baarends, & Awe, 2014). Failure of this could expose the 
DNA to fragmentation. Abnormalities in histone- to- protamine transi-
tion have been found to be associated with male infertility (Mengual, 
Ballescá, Ascaso, & Oliva, 2003; Nasr- Esfahani, Razavi, Mozdarani, 
Mardani, & Azvagi, 2004; Yu et al., 2014). Our recent studies showed 
that exogenous leptin administration increases DNA fragmentation 
and 8- hydroxy- 2- deoxyguanosine, a DNA marker of oxidative stress 
(Almabhouh et al., 2014, 2016). Altered histone- to- protamine ratio 
could make sperm DNA more susceptible to ROS attack and frag-
mentation. The impact of leptin on these processes has not been 
reported before, and it is possible that leptin either directly or through 
increased oxidative stress might be influencing these processes result-
ing in increased DNA fragmentation. This study therefore examined 
the effect of leptin on the transition of histone to protamine in adult 
rat spermatozoa.
2  | MATERIALS AND METHODS
2.1 | Experimental animals
Twelve- week- old male Sprague- Dawley rats were randomised into 
five groups consisting of control, leptin- , leptin–melatonin- 10 (LM10)- , 
leptin–melatonin- 20 (LM20)- and melatonin- 10 (M10)- treated groups 
with six rats per group. All leptin- treated groups received intraperito-
neal injections (i.p.) of leptin once daily for 42 days (60 μg kg−1 body 
weight; recombinant rat leptin; purity >95% Biovision, USA). Rats in 
the leptin- and melatonin- treated groups, in addition to leptin, were 
also given either 10 or 20 mg of melatonin kg−1 body weight day−1, 
in drinking water for 42 days. Melatonin- 10- treated group received 
only 10 mg of melatonin kg−1 body weight day−1 in drinking water for 
42 days. Control rats received 0.1 ml of 0.9% saline i.p. for 42 days. 
Rats were maintained in individual metabolic cages throughout the 
study period.
For the preparation of leptin, each vial containing 1 mg of leptin 
was first diluted in sterile water to a concentration of 1 mg ml-1. 
This solution was further diluted with 0.9% normal saline to a leptin 
concentration of 0.1 mg ml-1	and	stored	in	1-	ml	aliquots	at	−20°C.	
Required aliquots were removed for daily injections. Melatonin 
(Sigma- Aldrich, UK) was given in drinking water, and the concen-
tration of melatonin in drinking water was calculated based on the 
known average daily water consumption of the offspring. The daily 
water consumption was monitored to ensure that the required aver-
age melatonin was consumed. During the experiment, concentration 
of melatonin in the drinking water was adjusted to match the age- 
related increase in body weight and water consumption. Fresh drink-
ing water with or without melatonin was provided every other day. 
Drinking bottles were wrapped in aluminium foil to prevent degrada-
tion of melatonin by light. Body weight of control and experimental 
animals was monitored weekly. The study design and the use of ani-
mals in the study were approved by the Institute’s Animal Care and 
Users Committee.
2.2 | Sample collection
Upon completion of the treatment, the rats in each group were anaesthe-
tised with diethyl ether in a closed glass chamber. Laparotomy was per-
formed and both epididymides and testes were removed. These tissues 
were immediately washed in 0.9% saline to remove the blood stains. The 
epididymides were used for sperm count, morphology and histone- to- 
protamine	ratio	estimation.	The	testes	were	stored	at	−80°C	for	further	
analysis. Spermatozoa from the epididymides were collected according 
to the method used by Haron et al. (2010). An aliquot of the epididymal 
suspension was used for sperm count, percentage of spermatozoa with 
abnormal morphology and histone- to- protamine ratio estimation.
2.3 | Sperm count and morphology
Sperm count and percentage of spermatozoa with abnormal morphol-
ogy were estimated using a Makler counting chamber (Sefi Medical 
Instruments LTD.). The number of total and abnormal spermatozoa 
in a strip of 10 squares was counted. This number represented the 
concentration of spermatozoa in million per ml. This was repeated on 
another two strips, and then, the average was determined, and the 
concentration was expressed in million per ml. The percentage of 
spermatozoa with abnormal morphology was calculated by counting 
the number of spermatozoa with abnormal morphology, dividing by 
the total sperm count and multiplying the product by 100.
2.4 | Histone- to- protamine ratio in sperm nuclei
The ratio of histone to protamine in sperm nuclei was measured using 
a Sperm FuncR Histone Kit, aniline blue staining method (Bred Life 
Science China). A total of 200 sperm cells were evaluated under opti-
cal microscope at 100× objective. Positively stained spermatozoa 
(stained blue) had erroneous histone- to- protamine transition.
2.5 | Microarray analysis
The expression of genes involved in spermatogenesis was deter-
mined by microarray analysis. Total cellular RNA was extracted from 
testis tissue using innuPREP RNA Mini Kit (Analytik Jena, Germany) 
according to the manufacturer’s protocol, followed by treatment with 
DNase (Thermo Scientific). The RNA quality and concentration were 
assessed. About 200 ng of total RNA was used to prepare amplified 
cDNA using reagents provided in the Applause WT- Amp plus ST 
System Kit (Nugen technology, USA). The cDNA was then purified 
using QIAGEN’s MinElute Reaction Cleanup Kit. The purified cDNA 
was measured for concentration and purity. The Encore Biotin Module 
(Part No. 4200) was used to label the cDNA. Hybridisation was then 
performed on labelled cDNA using GeneChip Hybridization Kit 
(Affymetrix Rat GeneChip St 2) for 18 hr at GeneChip Hybridization 
Oven 640 (Affymetrix). Immediately following hybridisation, the 
GeneChip arrays were washed and stained using wash and stain kit 
in an automated GeneChip Fluidic Station 450 (Affymetrix), followed 
by scanning on a GeneChip Scanner. Data from microarray were 
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analysed as gene- level differential expression by Affymetrix soft-
ware (Expression Console- 1- 3- 1- 64 bit and Transcriptome Analysis 
Console- 2- 0- 64 bit). Gene expressions that were up- or downregu-
lated by at least 2- fold following leptin treatment or leptin–melatonin-
 20 treatment were compared to control. Six samples from each group 
were used for spermatogenesis- related gene expression studies using 
microarray analysis.
2.6 | Real- time PCR
Gene expression of histone acetyl transferase (HAT) that changed 
following treatment with leptin in the cDNA microarray analy-
sis was determined using iQ™ 5 Real Time PCR Detection System 
(Bio- Rad, USA). The paired primer sets included HAT forward 
(5′-	ACAATGTTCCGTGTTGAATATGC-	3′)	 and	 HAT	 reverse	 (5′
-	AGGTATGAAGTAAGGTTCCGAATG-	3′),	 GAPDH	 forward	 (5′
-	CAACTCCCTCAAGATTGTCAGCAA-	3′)	 and	 GAPDH	 reverse	
(5′-	GGCATGGACTGTGGTCATGA-	3′).	Normalisation	of	gene	expres-
sion was performed with GAPDH as housekeeping genes. The iQ™ 5 
Real Time PCR software (Bio- Rad, USA) was used to calculate the fold 
change of gene expression for all samples.
2.7 | Statistical analysis
Data were analysed using one- way ANOVA with post hoc Tukey’s 
analysis contained in SPSS version 20 (IBM, NY, USA) and expressed 
as mean ± SEM. Statistical significance was accepted at p < .05.
3  | RESULT
Body weight increased in all rats over the 6- week study period 
(Table 1). However, no significant differences were evident in body 
weight between the five groups.
Sperm count was significantly lower in leptin- only- and leptin– 
melatonin- 10 (LM10)- treated rats when compared to that in the 
 controls (p < .001 and .01, respectively; Table 2). No significant 
 difference was evident in sperm count between control and leptin–
melatonin- 20 (LM20)- and melatonin- 10 (M10)- treated rats.
The fraction of spermatozoa with abnormal morphology was sig-
nificantly higher in leptin- only- treated rats when compared to that 
in the controls (p < .001; Table 2). No significant differences were 
evident in the fraction of spermatozoa with abnormal morphology 
between melatonin- 10 (M10)- , leptin–melatonin- 10 (LM10)- , leptin–
melatonin- 20 (LM20)- and saline- treated controls.
No significant difference was evident in the fraction of sperma-
tozoa with abnormal histone transition between control and leptin–
melatonin- 20 (LM20)- and melatonin- 10 (M10)- treated rats. However, 
leptin- only- treated rats and leptin–melatonin- 10 (LM10)- treated rats 
had significantly elevated histone- to- protamine ratios when compared 
to the controls (p < .001 and .01, respectively; Figure 1).
Microarray analysis revealed approximately 161 genes involved in 
spermatogenesis that were differentially expressed in leptin- treated 
rats compared to those in the control rats. The expression of 141 of 
these genes was upregulated, whereas that of 20 genes was downreg-
ulated. The results showed that genes of basic nuclear protein that are 
responsible for the nucleosomal structure, such as histone, were upreg-
ulated in leptin- treated rats and unchanged in leptin–melatonin- 20- 
treated rats. Protamine 1 was significantly increased in leptin- treated 
rats, while protamine 2 was unchanged in the same rats. In contrast, 
in the leptin–melatonin- 20 group both protamine 1 and protamine 2 
were significantly increased compared to those in the control group. 
The expression of transition protein 1 (TNP1) was upregulated in 
leptin- treated rats, but transition protein 2 (TNP2) was unchanged. 
However, both transition proteins TNP1 and TNP2 were upregulated 
in leptin–melatonin- 20- treated rats. In addition, the expressions of 
histone acetyltransferase (HAT) and histone deacetylase 1 and histone 
TABLE  1 Body weight in control and leptin- treated rats
Groups
Body weight (g) 
Mean ± SEM
Body weight (g) 
Mean ± SEM
Day 0 Day 42
Control 345.83 ± 4.56 412.67 ± 6.48
Leptin 344.33 ± 5.02 411 ± 5.16
Leptin–melatonin 10 
(LM10)
343.5 ± 2.23 410 ± 6.8
Leptin–melatonin 20 
(LM20)
339.33 ± 2.4 403.67 ± 1.73
Melatonin 10 (M10) 342.33 ± 1.63 413.33 ± 3.99
Groups
Total sperm count ± SEM  
(Million/ml)
Fraction of abnormal spermatozoa 
Percentage ± SEM (%)
Control 9.9 ± 0.15 3.6 ± 0.3
Leptin 6.1 ± 0.25*** 10.9 ± 1.0***
Leptin–melatonin 10 
(LM- 10)
7.4 ± 0.33**,## 5.2 ± 0.4**,###
Leptin–melatonin 20 
(LM- 20)
10.1 ± 0.19### 5.0 ± 0.18**,###
Melatonin 10 (M- 10) 9.8 ± 0.11 4.1 ± 0.2
**p < .01, ***p < .001 compared to the control group.
##p < .01, ###p < .001 compared to the leptin- treated group.
TABLE  2 Total sperm count and 
fraction of spermatozoa with abnormal 
morphology in leptin- and melatonin- 
treated rats
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deacetylase 2 (HDAC1 and HDAC2) were significantly elevated in 
leptin- treated rats and unchanged in leptin–melatonin- 20- treated rats 
(Table 3; Figure 2).
mRNA expression of HAT in the testes was significantly higher in 
leptin- treated rats compared to that in leptin–melatonin- 20- treated 
and control rats (Figures 2). HAT expression was significantly lower in 
leptin–melatonin- 20- treated rats compared to that in the control.
A number of genes involved in oxidative stress were differentially 
expressed in the testes tissue of leptin- only- treated rat (Table 4). 
Five of these genes were of antioxidant enzymes including cata-
lase (Cat), glutathione peroxidase 7 (Gpx7), glutathione peroxidase 
1 (Gpx1), peroxiredoxin 1 (Prdx1) and glutathione S- transferase pi 
1 (Gstp1), which were significantly downregulated in leptin- treated 
rats. These genes were unchanged in LM- 20 rats when compared 
to controls. Cytosolic forms of superoxide dismutase 1 (Sod1) and 
glutathione s- transferase theta (Gstt4) were upregulated. Among the 
upregulated genes, respiratory chain reaction enzymes were dra-
matically upregulated in leptin- treated rats when compared to their 
expression in leptin–melatonin- 20- treated rats where they were 
unchanged (Table 4).
4  | DISCUSSION
The most significant finding of this study is the evidence of elevated 
histone- to- protamine ratios following 6 weeks of leptin treatment in 
the rat (Figure 1). To our knowledge, this is the first report on the 
effect of leptin on histone- protamine transition in spermatozoa and 
its prevention by melatonin. In addition, leptin- treated rats had lower 
sperm count and higher fraction of spermatozoa with abnormal mor-
phology when compared to saline- treated controls (Table 2). There 
was also evidence of upregulation of respiratory chain enzyme genes 
and downregulation of some of the antioxidant enzyme genes follow-
ing leptin treatment (Table 4). Most of the genes involved in histone- 
to- protamine transition process including the HAT cluster genes were 
also upregulated in leptin- treated rats (Table 3). Interestingly, all these 
effects were absent in rats given concurrent leptin and melatonin 
treatment.
Decreases in sperm count and increased fraction of spermato-
zoa with abnormal morphology following leptin treatment have been 
reported before (Abbasihormozi et al., 2013; Almabhouh et al., 2014; 
Haron et al., 2010, 2013). Although the precise mechanism for these 
remains unclear, increased intracellular levels of ROS following leptin 
treatment in rats have been reported previously (Abbasihormozi et al., 
2013). It is therefore possible that increased oxidative stress resulting 
from leptin administration increases DNA fragmentation, and conse-
quently higher fraction of spermatozoa with abnormal morphology 
and lower sperm count. The finding that melatonin prevented these 
suggests that this might indeed be the case given that melatonin is a 
known antioxidant (Table 2).
One very important process that takes place during spermatogen-
esis is the transition of the sperm chromatin from a nucleosome- to 
a protamine- based chromatin in which 85%–95% of histones in the 
DNA are replaced by protamines 1 and 2 (P1, P2). This facilitates 
the compaction of the nucleus and in a way protects the paternal 
DNA from damage and mutagenesis (Bao & Bedford, 2016; Barratt 
TABLE  3 Expression of histone- protamine genes involved in spermatogenesis in leptin- and leptin–melatonin- 20- treated rats
Gene description Gene symbol
Leptin- treated versus control Leptin–melatonin- 20 versus control
Status Fold change p- value Status Fold change p- value
Histone linker H1 domain, 
spermatid- specific 1
Hils1 Upregulated 3.32 .0132 Unchanged — —
H2A histone H2A Upregulated 2.59 .0439 Unchanged — —
Histone cluster 1 H1t Upregulated 5.29 .0012 Upregulated 2.16 .0054
Histone cluster 1 H2b H2B Upregulated 2.02 .0105 Unchanged — —
Protamine 1 PRM1 Upregulated 2.21 .0021 Upregulated 2.42 .0041
Protamine 2 PRM2 Unchanged — — Upregulated 2.59 .0227
Transition protein 1 TNP1 Upregulated 2.79 .0005 Upregulated 2.61 .0055
Transition protein 2 TNP2 Unchanged — — Upregulated 2.35 .0001
Histone acetyltransferase HAT Upregulated 2.17 .0266 Unchanged — —
Histone deacetylase 1 HDAC1 Upregulated 4.3 .0172 Unchanged — —
Histone deacetylase 2 HDAC2 Upregulated 4.07 .0044 Unchanged — —
F IGURE  1 Fraction of spermatozoa with abnormal histone 
transition in leptin- , Leptin–melatonin- and melatonin- treated rats. 
**p < 0.01, ***p < .001 compared to control
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F IGURE  2 Relative fold expressions 
(RFE) (mRNA) of HAT in control (C), 
leptin- treated (L) and leptin–melatonin- 
20- treated (LM- 20) rats. *p < .05; **p < .01 
compared to the control. ###p < .001 
compared to the leptin–melatonin- 20
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TABLE  4 Changes in expression of genes related to oxidative stress
Gene description Gene symbol
Leptin- treated versus control Leptin–melatonin- 20 versus control
Status Fold change p- value Status Fold change p- value
Catalase Cat Down- regulated −2.2 .001 Unchanged — —
Peroxiredoxin 1 Prdx1 Down- regulated −2.62 .022 Unchanged — —
Glutathione peroxidase 7 Gpx7 Down- regulated −2.27 .011 Unchanged — —
Glutathione peroxidase 1 Gpx1 Down- regulated −2.28 .009 Unchanged — —
Glutathione peroxidase 4 Gpx4 Down- regulated −3.45 .000 Unchanged
Glutathione S- transferase 
pi 1
Gstp1 Down- regulated −2.3 .014 Unchanged — —
Glutathione S- transferase, 
theta 4
Gstt4 Upregulated 10.5 .002 Unchanged — —
Superoxide dismutase 1, 
cytosolic form
Sod1 Upregulated 4.37 .001 Unchanged — —
Superoxide dismutase 2, 
mitochondrial
Sod2 Unchanged — — Unchanged — —
Superoxide dismutase 3 
extracellular
Sod3 Unchanged — — Unchanged — —
Nuclear factor erythroid 2 Nfe2 Unchanged — — Up- regulated 2.49 .0077
NADH dehydrogenase 
complex I, assembly factor 
3
Ndufaf3 Upregulated 3.68 .015 Unchanged — —
Succinate dehydrogenase 
complex
Sdh Upregulated 2.91 .000 Unchanged — —
Ubiquinol- cytochrome c 
reductase, Rieske 
iron–sulphur polypeptide 
1
Uqcrfs1 Upregulated 2.87 .003 Unchanged — —
Cytochrome C oxidase 
assembly factor 3
Coa3 Upregulated 4.42 .025 Unchanged — —
COX20 cytochrome C 
oxidase
Cox20 Upregulated 3.41 .000 Unchanged — —
Cytochrome b5 reductase 1 Cyb5r1 Upregulated 2.69 .010 Unchanged — —
Ubiquinol- cytochrome c 
reductase core protein 2
Uqcrc2 Upregulated 2.67 .008 Unchanged — —
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et al., 2010; Conwell et al., 2003; Oliva, 2006; Rathke et al., 2014). 
In the present study, the ratio of histone to protamine was signifi-
cantly higher in leptin- treated rats compared to that in the controls. 
Besides that, the expression of histone cluster genes (H1, H2A and 
H2B) and protamine 1 (PRM1) gene was significantly upregulated in 
leptin- treated rats compared to that in the control (Table 3). The pro-
tamine 2 gene was, however, not upregulated. The exact reason for 
this is unclear. Protamines 1 and 2 are usually expressed in nearly 
equal quantities. Altered P1/P2 ratios have, however, been associated 
with increased DNA fragmentation (Garcia- Peiro et al., 2011; Simon, 
Castillo, Oliva, & Lewis, 2011). Elevated or reduced P1/P2 ratios 
have been observed in some infertile men and are often associated 
with severe spermatogenesis defects (Carrell et al., 2007; Corzett, 
Mazrimas, & Balhorn, 2002). A reduction in P2 protamine content 
has also been reported in infertile males (Bach, Glander, Scholz, & 
Schwarz, 1990; Balhorn, Reed, & Tanphaichitr, 1988; Bench, Corzett, 
De Yebra, Oliva, & Balhorn, 1998; De Yebra, Ballesca, Vanrell, Bassas, 
& Oliva, 1993; De Yebra et al., 1998). Histone acetylation has been 
known to play an important role in spermatogenesis. The expression 
of histone acetyl transferases (HAT) and histone deacetylase (HDAC) 
was significantly higher in leptin- treated rats compared to that in con-
trol and leptin–melatonin- 20- treated rats (Table 3). Histone acetyl-
ation of lysine residues is regulated by histone acetyltransferases 
(HAT) to facilitate acetylation, whereas histone deacetylases (HDAC) 
decrease acetylation (Davie, 1998; Kim, Jee, Lee, Suh, & Kim, 2014b; 
Kim et al., 2014a). Acetylation- associated enzyme activity and sperm 
DNA fragmentation index are positively correlated with histone ace-
tyl transferase (HAT) activity (Kim et al., 2014a, 2014b). When his-
tones are hyperacetylated, their affinity to DNA is decreased due to 
a loss of their positive charge, and this makes the chromatin struc-
ture more relaxed, permitting transcription to occur (Turner, 1991). 
In addition, when histones are hyperacetylated, histone bound to 
DNA becomes less tightly compact and more susceptible to damage 
and DNA fragmentation. The higher expression of the HAT genes 
suggests that leptin hastens acetylation, making the chromatin struc-
ture less compact. Given that leptin is also known to increase ROS 
production, the presence of increased ROS around chromatin that is 
less compact could lead to DNA damage and fragmentation. Leptin 
has been shown to increase superoxide anion production (O2
·−) in 
primary cultured vascular smooth muscle cells (Martínez- Martínez 
et al., 2014), in aortic endothelial cells (Yamagishi et al., 2001), and 
cause peroxynitrite- mediated oxidative stress in steatohepatic lesions 
(Chatterjee et al., 2013). Increased levels of sperm 8- OHdG, a marker 
of DNA damage due to oxidative stress, and sperm DNA fragmen-
tation following leptin treatment in Sprague- Dawley rats have been 
reported recently (Almabhouh et al., 2014). Oxidative stress induced 
by cigarette smoking is also strongly associated with abnormalities 
in histone- to- protamine transition and with alterations in prota-
mine mRNA expression in human spermatozoa (Hammadeh, Hamad, 
Montenarh, & Fischer- Hammadeh, 2010; Yu et al., 2014).
Concurrent daily administration of melatonin through drinking 
water prevented the adverse effects of leptin, particularly when given 
at a dose of 20 mg kg-1 body weight per day. Melatonin has been 
reported to prevent gentamicin- induced testicular toxicity in rats (Kim 
et al., 2014a, 2014b). In addition, it has also been shown to have potent 
protective effects against anticancer drug- induced testicular toxicity, 
including	reduced	sperm	count	and	lowered	sperm	motility	(Ateşşahin	
et al., 2006; Ilbey et al., 2009). Several studies have demonstrated that 
melatonin prevents oxidative damage and testicular toxicity induced 
by ochratoxin A, cyclophosphamide, electromagnetic radiation, testic-
ular ischaemia–reperfusion and hypoxia and also supported the anti-
oxidant redox system in the testis (Chabra, Shokrzadeh, Naghshvar, 
Salehi, & Ahmadi, 2014; Koksal et al., 2012; Malekinejad et al., 2011; 
Oksay et al., 2012; Zepeda et al., 2012). More interestingly, leptin- 
induced increase in O2
· in primary cultured vascular smooth muscle 
cells was reportedly prevented by melatonin (Martínez- Martínez et al., 
2014). It is therefore possible that melatonin reduced the adverse 
effects of leptin by reducing the level of oxidative stress.
In conclusion, it appears that exogenous leptin administration 
adversely affects histone- to- protamine transition during spermato-
genesis. It also significantly increases the expression of genes involved 
in replacement of histone to protamine. These effects are prevented 
by concurrent administration of melatonin.
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